ISCT 2016

August 19th, 2016 | Posted by webmaster in News | Uncategorized - (Comments Off on ISCT 2016)

CT’s contribution to ISCT 2016

Representatives from Cell Therapies presented at ISCT Singapore on the following topics:

Apheresis – Douglas Watson, Cell Therapy Specialist

Initial Comparison of 3 apheresis platforms for supporting the collection of CD3+ cells for CAR-T production

Flow Cytometry – Alex Rizzitelli, Cell Therapy Specialist

Flow cytometry tools for characterisation of GMP cell products

COGS Optimisation – Tim Oldham, CEO

COGS by Design – A systems approach to achieving commercially viable cellular therapy products

Australian Cell Therapy Landscape – Tim Oldham, CEO

Advantage Australia – A Stepping stone to Asian and global development of cellular therapies

Recently Closed Positions

November 12th, 2014 | Posted by webmaster in Uncategorized - (Comments Off on Recently Closed Positions)

Cell Therapy Specialist (Gene Modified T-cell Immunotherapies)
Project Portfolio Manager
Cell Therapy Development Manager
GMP Facility Manager
Quality and Compliance Officer
Assistant Accountant